RNase L in Health and Disease-What Did We Learn Recently?

References

• Suhadolnik RJ, Reichenbach NL, Hitzges P, et al. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. ClM Infect Dis 1994; 18 (Suppl. 1):S96–S104.
   Google Scholar
• Sen GC. Viruses and interferons. Annu Rev Microbiol 2001; 55:255–281.
   PubMed Web of Science ®Google Scholar
• Der SD, Zhou A, Williams BRG, Silverman RH. Identification of genes differ-entially regulated by interferon a, 13, or y using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95:15623–15628.
   PubMed Web of Science ®Google Scholar
• Vojdani A, Choppa PC, Lapp CW. Down regulation of RNase L inhibitor corre-lates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome. J ClM Lab Immunol 1998; 50:1–16.
   Google Scholar
• Grolleau A, Kaplan MJ, Hanash SM, Beretta L, Richardson B. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J ClM Invest 2000; 106:1561–1568.
   Google Scholar
• Schattner A, Cori Y, Hahn T, Sirota P. No evidence for autoimmunity in schizo-phrenia. J Autoimmun 1996; 9:661–666.
   PubMed Web of Science ®Google Scholar
• Bonnevie-Nielsen V, Martensen PM, Justesen J, et al. The antiviral 2',5 '-oligoadenylate synthetase is persistently activated in type 1 diabetes. Clin Immunol 2000; 96:11–18.
   Google Scholar
• Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002; 3:373–382.
   PubMed Web of Science ®Google Scholar
• Player MR, Torrence PF. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol Ther 1998; 78:55–113.
   PubMed Web of Science ®Google Scholar
• Natelson BH. A status report on chronic fatigue syndrome. Environm Health Perspect 2002; 110:673–677.
   PubMed Web of Science ®Google Scholar
• De Meirleir K, Bisbal C, Campine I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108: 99–105.
   PubMed Web of Science ®Google Scholar
• Bastide L, Demettre E, Martinand-Mari C, Lebleu B. Interferon and the 2-5A/pathway. In: P. Englebienne & K. De Meirleir (Eds.), Chronic Fatigue Syn-drome, A Biological Approach. 2002; (pp. 1–15). Boca Raton: CRC Press.
   Google Scholar
• Hartmann R, Norby PL, Martensen PM, et al. Activation of 2'-S' oligo-adenylate synthetase by single-stranded and double-stranded RNA aptamers. J Biol Chem 1998; 273:3236–3246.
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of dou-ble-stranded RNA and activation of NF-kB by Toll-like receptor 3. Nature 2001; 413:732–738.
   PubMed Web of Science ®Google Scholar
• Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacte-rial CpG DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002; 32:1958–1968.
   Google Scholar
• Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709–760.
   PubMed Web of Science ®Google Scholar
• Magnusson, M, Magnusson S, Vallin H, Ronnblom L, Alm GV. Importance of CpG dinucleotides in activation of natural IFN-a-producing cells by a lupus-related oligodeoxynucleotide. Scand J Immunol 2001; 54:543–550.
   PubMed Web of Science ®Google Scholar
• Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002; 30:181–184.
   PubMed Web of Science ®Google Scholar
• Rokman A, Ikonen T, Seppala EH, et al. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Genet 2002; 70:1299–1304.
   Web of Science ®Google Scholar
• Englebienne P, Verhas M, Herst CV, De Meirleir K. Type I interferons induce proteins susceptible to act as thyroid receptor (TR) corepressors and to signal the TR for destruction by the proteasome: possible etiology for unexplained chronic fatigue. Med Hypotheses 2002; in press.
   Google Scholar
• Dong B, Silverman RH. 2-5A-dependent RNase molecules dimerize during ac-tivation. J Biol Chem 1995; 270:4133–4137.
   PubMed Web of Science ®Google Scholar
• Dong B, Silverman RH. Alternative function of a protein kinase homology do-main in 2',5'-oligoadenylate dependent RNase L. Nucleic Acids Res 1999; 27:439–445.
   PubMed Web of Science ®Google Scholar
• Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T. Cloning and charac-terization of a RNase L inhibitor. J Biol Chem 1995; 270:13308–13317.
   PubMedGoogle Scholar
• Englebienne P, Herst CV, D'Haese A, et al. Ribonuclease L inhibitor: a member of the ATP-binding cassette super family. In: P. Englebienne & K. De Meirleir (Eds.), Chronic Fatigue Syndrome, A Biological Approach 2002 (pp. 73–97). Boca Raton: CRC Press.
   Google Scholar
• Zimmerman C, Klein KC, Kiser PK, et al. Identification of a host protein essen-tial for assembly of immature HIV-1 capsids. Nature 2002; 415:88–92.
   PubMed Web of Science ®Google Scholar
• Castelli J, Wood KA, Youle RJ. The 2-5A system in viral infection and apoptosis. Biomed Pharmacother 1998; 52:386–390.
   PubMedGoogle Scholar
• Bisbal C, Silhol M, Laubenthal H, et al. The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol Cell Biol 2000; 20:4959–4969.
   PubMed Web of Science ®Google Scholar
• Le Roy F, Bisbal C, Silhol M, Martinand C, Lebleu B, Salehzada T. The 2-5A/RNase L/RLI pathway regulates mitochondria' mRNAs stability in IFNa-treated H9 cells. J Biol Chem 2001; 276:48473–48482.
   PubMed Web of Science ®Google Scholar
• Rusch L, Zhou A, Silverman RH. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-f3. J Intel f eron Cytokine Res 2000; 20:1091–1100.
   Google Scholar
• Li XL, Blackford JA, Judge CS, et al. RNase-L-dependent destabilization of in-terferon-induced mRNAs. J Biol Chem 2000; 275:8880–8888.
   PubMed Web of Science ®Google Scholar
• D' Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E Jr, Borden EC. In vi-tro and in vivo secretion of human I5G15, an IFN-induced immunomodulatory cytokine. J Immunol 1996; 157:4100–4108.
   PubMed Web of Science ®Google Scholar
• Loeb KR, Haas AL. The interferon-inducible 15-kDa ubiquitin homolog conju-gates to intracellular proteins. J Biol Chem 1992; 267:7806–7813.
   PubMed Web of Science ®Google Scholar
• Hamerman JA, Hayashi F, Schroeder LA, et al. Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol 2002; 168:2415–2423.
   PubMed Web of Science ®Google Scholar
• Li XL, Hassel BA. Involvement of proteasomes in gene induction by interferon and double-stranded RNA. Cytokine 2001; 14:247–252.
   PubMed Web of Science ®Google Scholar
• D'Cunha J, Knight E Jr, Haas AL, Truitt RL, Borden EC. Immunoregulatory properties of I5G15, an interferon-induced cytokine. Proc Natl Acad Sci USA 1996; 93:211–215.
   PubMed Web of Science ®Google Scholar
• Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. UBP43 (USP18) specifically removes I5G15 from conjugated proteins. J Biol Chem 2002; 277:9976–9981.
   Google Scholar
• Malakhova O, Malakhov M, Hetherington C, Zhang DE. Lipopolysaccharide activates the expression of 15G15-specific protease UBP43 via interferon regulatory factor 3. J Biol Chem 2002; 277: 14703–14711.
   Google Scholar
• Suhadolnik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17:377–385.
   Google Scholar
• Shetzline SE, Suhadolnik RJ. Characterization of a 2',5'-oligoadenylate (2-5A)-dependent 37-kDa RNase L: azido photoaffinity labeling and 2-5A-dependent activa-tion. J Biol Chem 2001; 276:23707–23711.
   PubMed Web of Science ®Google Scholar
• Shetzline SE, Martinand-Mari C, Reichenbach NL, et al. Structural and func-tional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome. J Intel feron Cytokine Res 2002; 22:443–456.
   PubMed Web of Science ®Google Scholar
• Demettre E, Bastide L, D'Haese A, et al. Ribonuclease L proteolysis in periph-eral blood mononuclear cells of chronic fatigue syndrome patients. J Biol Chem 2002; 277:35746–35751.
   Google Scholar
• Roelens S, Herst CV, D'Haese A, et al. G-actin cleavage parallels 2-5A-de-pendent RNase L cleavage in peripheral blood mononuclear cells. Relevance to a pos-sible serum-based screening test for deregulations in the 2-5A pathway. J Chronic Fatigue Syndrome 2001; 8:63–82.
   Google Scholar
• Marie I, Blanco J, Rebouillat D, Hovanessian AG. 69-kDa and 100-kDa isoforms of interferon-induced (2'-5') oligoadenylate synthetase exhibit differential catalytic parameters. Eur J Biochem 1997; 248:558–566.
   PubMedGoogle Scholar
• De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K. Exercise capacity in chronic fatigue syndrome. Arch Intern Med 2000; 160:3270–3277.
   Google Scholar
• Englebienne P, Herst CV, De Smet K, D'Haese A, De Meirleir K. Interactions between RNase L ankyrin-like domain and ABC transporters as a possible origin for pain, ion transport, CNS and immune disorders of chronic fatigue immune dysfunction syndrome. J Chronic Fatigue Syndrome 2001; 8:83–102.
   Google Scholar
• Chaudhuri A, Watson WS, Pearn J, Behan PO. The symptoms of chronic fa-tigue syndrome are related to abnormal ion channel function. Med Hypotheses 2000; 54:59–63.
   PubMed Web of Science ®Google Scholar
• De Becker P, McGregor N, De Smet K, De Meirleir K. Current advances in CFS therapy. In: P. Englebienne & K. De Meirleir (Eds.), Chronic Fatigue Syndrome, A Bi-ological Approach. 2002; (pp. 229–263). Boca Raton: CRC Press.
   Google Scholar
• Ushijima H, Rytik PG, Schacke H, Scheffer U, Muller WE, Schroder HC. Mode of action of the anti-AIDS compound poly(I).poly(C12U (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase. J Inter-feron Res 1993; 13: 161–171.
   Google Scholar
• Vojdani A, Ghoneum M, Choppa PC, Magtoto L, Lapp CW. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Intern Med 1997; 242:465–478.
   Google Scholar